Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis

In patients with active rheumatoid arthritis despite methotrexate treatment, a single course of two infusions of rituximab, alone or in combination with either cyclophosphamide or continued methotrexate, provided significant improvement in disease symptoms at both weeks 24 and 48.